UPL Share Price: Shares of UPL surged 5.6% to Rs 552.70 on Tuesday after the agrochemical company reported a net loss of Rs 443 crore for Q...

UPL is a strong buy for long-term investors looking for a stock in the agrochemical industry. The company has experienced a 50% fall in sto...

UPL Global Crop Protection CEO Mike Frank expects pricing pressure in the post-patent segment to persist in H1 2022 but believes the compan...

Revenue from operations increased 21% on-year to Rs 13,679 crore, higher than the estimated Rs 13,076 crore

Two promoter entities, Harmonic Ventures and Suresight Ventures, bought nearly 6.7 million shares from the open market, trading data on pro...

UPL Ltd. key Products/Revenue Segments include Agrochemicals, Export Incentives, Sale of services, Other Operating Revenue, Royalty Income ...

UPL Ltd., incorporated in the year 1985, is a Large Cap company (having a market cap of Rs 56911.07 Crore) operating in Pesticides/Agro Che...

“In the last week or so, some of the pharma companies have corrected significantly. Glenmark, Cadila and Aurobindo Pharma are three stocks ...

UPL, formerly United Phosphorus, is the world’s fifth-largest agrochemicals company.

First Indian co to raise sustainability linked loans; to reduce carbon emissions, water usage and waste over 5 years

Investec, Edelweiss and CLSA have maintained buy ratings. Kotak Institutional Equities has maintained a sell rating.

The brokerage’s estimate of adjusted net debt/EBITDA of 2 times for FY22 could possibly trigger a rating upgrade in FY22.

At 5.4 times one-year forward EV/EBITDA, the risk-reward is favorable and offers a good opportunity to enter the stock.

We gained market share in the agricultural market this quarter.

Likely benefits from the US-China trade war, growing Latin American business, and reasonable valuations after the recent price correction h...

UPL rallied over 18% in a matter on two trading sessions after the company reported consolidated numbers which were ahead of consensus.

Stock has gained over 10 per cent in the last five sessions and with the momentum picking up in midcaps, the rally may continue in the near...